CA1014947A - Steroids of the pregnane series having anaesthetic activity - Google Patents

Steroids of the pregnane series having anaesthetic activity

Info

Publication number
CA1014947A
CA1014947A CA171,026A CA171026A CA1014947A CA 1014947 A CA1014947 A CA 1014947A CA 171026 A CA171026 A CA 171026A CA 1014947 A CA1014947 A CA 1014947A
Authority
CA
Canada
Prior art keywords
steroids
pregnane series
anaesthetic activity
anaesthetic
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA171,026A
Other languages
English (en)
Other versions
CA171026S (en
Inventor
Barry E. Ayres
Leslie Stephenson
Robin Lawrence
Gordon H. Phillipps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of CA1014947A publication Critical patent/CA1014947A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA171,026A 1972-05-12 1973-05-11 Steroids of the pregnane series having anaesthetic activity Expired CA1014947A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2248972A GB1436324A (en) 1972-05-12 1972-05-12 Anaesthetic 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
CA1014947A true CA1014947A (en) 1977-08-02

Family

ID=10180241

Family Applications (1)

Application Number Title Priority Date Filing Date
CA171,026A Expired CA1014947A (en) 1972-05-12 1973-05-11 Steroids of the pregnane series having anaesthetic activity

Country Status (13)

Country Link
US (1) US3998829A (enExample)
JP (1) JPS4948652A (enExample)
AU (1) AU474687B2 (enExample)
BE (1) BE799433A (enExample)
CA (1) CA1014947A (enExample)
DE (1) DE2323950A1 (enExample)
DK (1) DK135775B (enExample)
FR (1) FR2184711B1 (enExample)
GB (1) GB1436324A (enExample)
IE (1) IE38863B1 (enExample)
LU (1) LU67585A1 (enExample)
NL (1) NL7306606A (enExample)
ZA (1) ZA733218B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613463A (en) * 1984-11-01 1986-09-23 The Upjohn Company Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
JPH072555Y2 (ja) * 1991-06-03 1995-01-25 日野自動車工業株式会社 車輛の前後方向兼用ウインチ
PT837874E (pt) * 1995-06-06 2005-03-31 Euro Celtique Sa Esteroides neuroactivos da serie androstano e pregnano
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
US6143737A (en) * 1995-06-23 2000-11-07 Georgetown University Progesterone analogs to reverse multidrug resistance
UA73736C2 (en) * 1999-04-29 2005-09-15 Euro Celtic S A Method for alleviating or preventing insomnia and inducing anesthesia
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
EP4717314A2 (en) 2011-10-14 2026-04-01 Sage Therapeutics, LLC 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016082789A1 (en) * 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1107662B (de) * 1959-07-04 1961-05-31 Merck Ag E Verfahren zur Herstellung von Mannichbasen von Steroiden bzw. von deren Saeureadditionssalzen
US3042691A (en) * 1960-05-11 1962-07-03 Pfizer & Co C 5alpha,21-dibromo-6beta-fluoro-21-methyl-pregnanes and process for making same
FR1764M (fr) * 1962-02-20 1963-04-08 Roussel Uclaf Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou viscérale.
US3201425A (en) * 1963-12-10 1965-08-17 American Cyanamid Co 20-alkoxy-delta20-21-carboxaldehydes of the pregnane series and method of preparing the same
GB1089945A (en) * 1965-09-23 1967-11-08 British Drug Houses Ltd Steroidal-6-spirocyclopropyl-4-en-3-ones
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
DE1941226A1 (de) * 1969-08-13 1971-02-18 Degussa Basisch substituierte Ketosteroide
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same

Also Published As

Publication number Publication date
IE38863B1 (en) 1978-06-21
DE2323950A1 (de) 1973-12-13
AU474687B2 (en) 1976-07-29
AU5561673A (en) 1974-11-14
US3998829A (en) 1976-12-21
DK135775C (enExample) 1977-11-21
ZA733218B (en) 1974-05-29
LU67585A1 (enExample) 1973-07-24
BE799433A (fr) 1973-11-12
FR2184711A1 (enExample) 1973-12-28
GB1436324A (en) 1976-05-19
FR2184711B1 (enExample) 1977-01-07
JPS4948652A (enExample) 1974-05-11
DK135775B (da) 1977-06-20
IE38863L (en) 1973-11-12
NL7306606A (enExample) 1973-11-14

Similar Documents

Publication Publication Date Title
AU473714B2 (en) Anti-inflammatory steroids of the androstane series
AU474687B2 (en) Pregnane anaesthetics
AU475168B2 (en) Anaesthetic pregnanes
ZA734037B (en) Compounds of the androstane series having anaesthetic activity
IL41160A0 (en) Novel steroids of the pregnane series and their preparation
AU468918B2 (en) Novel steroids ofthe pregnane series
CA1010847A (en) Compounds of the pregnane series having useful anaesthetic activity and processes for their preparation
AU2369170A (en) New 21-mercapto-steroids of the pregnane series and a procesas for their manufacture
AU473594B2 (en) Anaesthetic steroids ofthe pregnane series
CA995662A (en) Compounds of the pregnane series having useful anaesthetic activity and processes for their preparation
CA1020546A (en) 21-sulfinyl steroids
CA992068A (en) Steroid having anaesthetic activity
AU477138B2 (en) Anaesthetic pregnanes
AU475105B2 (en) Anaesthetic pregnanes
CA988508A (en) Steroids having useful anaesthetic activity and processes for their preparation
CA955931A (en) Steroids of the pregnane series
CA996928A (en) Compounds of the androstane series having anaesthetic activity
AU485903B2 (en) 2-2-dimethyl steroids
CA892572A (en) Steroids of the pregnane series
CA981251A (en) Compounds of the pregnane series having useful anaesthetic activity
CA907001A (en) Process for the preparation of dl-19-norpregna-4,16-diene-3,20-dione and intermediate therefor
CA899854A (en) Manufacture of new 6-fluoro steroids of the androstane series
CA832442A (en) 17 alpha-alkylated steroids of the pregnane series
CA911428A (en) 21-mercapto-steroids of the pregnane series and a process for their manufacture
CA849516A (en) Heterocyclic steroids of the pregnane series